IL1B and breast carcinoma: In a mouse model of human breast cancer, fibroblast growth factor receptor 1-induced mammary tumorigenesis is associated with local production of IL-1β and can be blocked by treatment with an IL-1β neutralizing antibody (Reed et al., 2009).